Carmell Therapeutics
Pittsburgh, US
Biotech
Founders & leadership
AI
Alan I. WestExecutive Officer, Director
JI
James I. JordanDirector
PI
Paul I. KornblithExecutive Officer, Director
RI
Richard I. UptonDirector
WI
William I. NewlinDirector
Reported raises · per SEC filings
Form D private placements$2.4MraisedSep 2020 · 37 investors · Biotechnology
Rule 506(b)$50KraisedJul 2020 · 1 investors · Biotechnology
Rule 506(b)$5.2MraisedMar 2019 · 44 investors · Biotechnology
Rule 506(b)$439.2KraisedApr 2018 · 6 investors · Biotechnology
Rule 506(b)$2MraisedDec 2017 · 25 investors · Biotechnology
Rule 506(b)$1.1MraisedApr 2017 · 25 investors · Biotechnology
Rule 506(b)$774.9KraisedFeb 2016 · 8 investors · Biotechnology
Rule 506(b)$137.2KraisedAug 2015 · 5 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.